177 related articles for article (PubMed ID: 23737867)
1. Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.
Lin J; Zhou J; Xu W; Zhong X; Hong Z; Peng J
Exp Ther Med; 2013 May; 5(5):1293-1300. PubMed ID: 23737867
[TBL] [Abstract][Full Text] [Related]
2. Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.
Lin J; Zhou J; Xu W; Hong Z; Peng J
Exp Ther Med; 2014 Jul; 8(1):118-124. PubMed ID: 24944609
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells.
Lin J; Zhou J; Zhong X; Hong Z; Peng J
Mol Med Rep; 2015 Mar; 11(3):2207-14. PubMed ID: 25394909
[TBL] [Abstract][Full Text] [Related]
4. Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis.
Zheng H; Xu W; Lin J; Peng J; Hong Z
Mol Med Rep; 2013 Mar; 7(3):848-54. PubMed ID: 23314795
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
Zhong X; Lin J; Zhou J; Xu W; Hong Z
Mol Med Rep; 2015 Aug; 12(2):1699-708. PubMed ID: 25825141
[TBL] [Abstract][Full Text] [Related]
6. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations.
Elbaz EM; Darwish A; Gad AM; Abdel Rahman AAS; Safwat MH
Eur J Pharmacol; 2023 Oct; 957():175993. PubMed ID: 37598927
[TBL] [Abstract][Full Text] [Related]
7. miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia.
Liu L; Wan Y; Shen A; Zhao J; Lin J; Zhong X; Zhang Y; Hong Z
Evid Based Complement Alternat Med; 2015; 2015():365484. PubMed ID: 26294924
[TBL] [Abstract][Full Text] [Related]
8. Qianliening capsule () inhibits human prostate cell growth via induction of mitochondrion-dependent cell apoptosis.
Hong ZF; Lin JM; Zhong XY; Li Y; Zhou JH; Xu W; Peng J
Chin J Integr Med; 2012 Nov; 18(11):824-30. PubMed ID: 23086486
[TBL] [Abstract][Full Text] [Related]
9. Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase
Youn DH; Park J; Kim HL; Jung Y; Kang J; Lim S; Song G; Kwak HJ; Um JY
Front Pharmacol; 2018; 9():773. PubMed ID: 30061836
[TBL] [Abstract][Full Text] [Related]
10. An inhibitory effect of Berberine from herbal Coptis chinensis Franch on rat detrusor contraction in benign prostatic hyperplasia associated with lower urinary tract symptoms.
Miao L; Yun X; Yang X; Jia S; Jiao C; Shao R; Hao J; Chang Y; Fan G; Zhang J; Geng Q; Wichai N; Gao X
J Ethnopharmacol; 2021 Mar; 268():113666. PubMed ID: 33301912
[TBL] [Abstract][Full Text] [Related]
11. The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia.
Afify H; Abo-Youssef AM; Abdel-Rahman HM; Allam S; Azouz AA
Toxicol Appl Pharmacol; 2020 Sep; 402():115122. PubMed ID: 32628957
[TBL] [Abstract][Full Text] [Related]
12. Shuangshi Tonglin Capsule treats benign prostatic hyperplasia through the ROS/NLRP3 signaling pathway.
Wang Z; Mao Q; Yuan Y; Wang C; Wei H
Int Urol Nephrol; 2024 Apr; 56(4):1259-1271. PubMed ID: 38036804
[TBL] [Abstract][Full Text] [Related]
13. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
14. Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome.
Zang L; Tian F; Yao Y; Chen Y; Shen Y; Han M; Meng Z; Fan S; Zhang X; Cai T; Gao Q; Zhang Y; Lu J
J Cell Mol Med; 2021 Jun; 25(12):5753-5768. PubMed ID: 33982874
[TBL] [Abstract][Full Text] [Related]
15. Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.
Kim SK; Park HK; Choi HS; Yoo KH; Chung JH
Int Neurourol J; 2016 Dec; 20(4):363-370. PubMed ID: 28043105
[TBL] [Abstract][Full Text] [Related]
16. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
[TBL] [Abstract][Full Text] [Related]
17. Anti-Proliferative Effects of Standardized
Jin BR; Cheon SY; Kim HJ; Kim MS; Lee KH; An HJ
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334082
[No Abstract] [Full Text] [Related]
18. Yongdamsagan-tang, a traditional herbal formula, inhibits cell growth through the suppression of proliferation and inflammation in benign prostatic hyperplasia epithelial-1 cells.
Park E; Lee MY; Seo CS; Jeon WY; Shin HK
J Ethnopharmacol; 2017 Sep; 209():230-235. PubMed ID: 28782621
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Effects of Polymerized Anthocyanin from Grape Skin on Benign Prostatic Hyperplasia.
Choi YJ; Fan M; Tang Y; Yang HP; Hwang JY; Kim EK
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31615010
[TBL] [Abstract][Full Text] [Related]
20. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
